Top news of September: Penicillin allergy de-labeling, hidden food allergies, more
Click Here to Manage Email Alerts
Healio compiled the most-read news in allergy, asthma and immunology posted in September.
Highlights include advice for getting into the media game; guidelines for non-allergists who want to de-label patients with reported penicillin allergies; the differences between hidden food allergies and hidden food allergens; a questionnaire that can help predict future asthma exacerbations; navigating simultaneous flu and allergy seasons; and more.
Vitamin D supplementation mitigates inflammation in eosinophilic esophagitis
Vitamin D is a natural antagonist for IL-13, which governs epithelial tissue inflammation in eosinophilic esophagitis, according to a study published in Gut. Read more.
Guidelines describe how non-allergists can de-label penicillin allergies
People who mistakenly believe they have a penicillin allergy are at risk for multiple adverse outcomes. Expanding de-labeling services would help optimize the care they receive, researchers reported in guidelines presented in Clinical & Experimental Allergy. Read more.
Hidden food allergies vs. hidden food allergens: What’s the difference?
In his latest column, Douglas H. Jones, MD, addresses the retail home allergy tests that many patients are now trying and how these results are impacting their outcomes. Read more.
Doctors can use the media to fight misinformation, educate public, become stars
Lipi Roy, MD, MPH, FASAM, has appeared on television more than 350 times discussing a variety of health issues. During her presentation at the Women in Medicine Summit, she explained how you can be a star too — and why these media appearances are important. Read more.
Eating peanuts, eggs while breastfeeding has unclear impact on infant allergies
Whether a maternal diet rich in egg and peanut has any impact on allergies among infants during the first 6 months of breastfeeding remains unclear, according to a letter published in Pediatric Allergy and Immunology. Read more.
Questionnaire a ‘powerful predictor’ of future asthma exacerbations
The free and online Asthma Impairment and Risk Questionnaire comprises 10 yes/no items designed to assess both symptom impairment and exacerbation risk. Read more.
Biomarkers predict effectiveness of dupilumab treatment for moderate to severe asthma
Dupilumab significantly reduced exacerbations and improved lung function among patients with type 2 biomarkers meeting or surpassing Global Initiative for Asthma thresholds, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice. Read more.
Q&A: How to navigate simultaneous flu and allergy seasons
What happens when patients come in with symptoms ranging from congestion and sneezing to cough and fever? Stanley M. Fineman, MD, former president of the American College of Allergy, Asthma & Immunology, offers some advice. Read more.
Q&A: Expanded rollout of adenosine deaminase deficiency newborn screenings recommended
Nicholas L. Hartog, MD, FAAAAI, FACAAI, explains how tandem mass spectroscopy, which costs next to nothing to implement, can identify cases of adenosine deaminase deficiency that other screenings miss, potentially saving lives. Read more.
High dietary fiber intake in childhood reduces risk for allergic rhinitis in adulthood
A study published in Clinical and Translational Allergy found an inverse overall association between fiber intake at age 8 years and allergic rhinitis symptoms at age 24 years. Read more.